Background: Prednisone is a major factor of bone loss after kidney transplantation. The role of hyperparathyroidism and immunosuppressors is less clear.
Methods: Thirty-three patients (14 men, 19 women) with ESRD were followed prospectively for 18 months after kidney transplantation.